Advertisement

The Ubiquitination of Spinal MrgC Alleviates Bone Cancer Pain and Reduces Intracellular Calcium Concentration in Spinal Neurons in Mice

  • Yu-E SunEmail author
  • Hua-Ye Xu
  • Jing Hao
  • Wen-Wen Huo
  • Yue Qian
  • Bai-Ling Hou
Original Paper
  • 7 Downloads

Abstract

Mas-related G-protein-coupled receptor subtype C (MrgC) has been shown to play an important role in the development of bone cancer pain. Ubiquitination is reported to participate in pain. However, whether MrgC ubiquitination plays a role in bone cancer pain remains unclear. To answer this question, we designed and performed this study. Osteosarcoma cells were implanted into the intramedullary space of the right femurs of C3H/HeJ mice to induce progressive bone cancer pain. MrgC agonist bovine adrenal medulla 8–22 (BAM 8–22) or MrgC antagonist anti-MrgC antibody were injected intrathecally on day 14 after bone cancer pain was successfully induced. The pain behaviors, the MrgC ubiquitination levels and intracellular calcium concentration in spinal neurons were measured before and after injection, respectively. With comparison to normal and sham group, mice in tumor group exhibited serious bone cancer pain on day 14, and the level of MrgC ubiquitination and intracellular calcium concentration in spinal neurons was significantly higher. Intrathecal injection of BAM 8–22 significantly alleviated bone cancer pain, increased the MrgC ubiquitination level and decreased intracellular calcium concentration in spinal neurons; however, these effects were reversed by administration of anti-MrgC antibody. Our study reveals that MrgC ubiquitination participates in the production and maintenance of bone cancer pain in mice, possibly through the regulation of intracellular calcium concentration in mice spinal neurons.

Keywords

Bone cancer pain Mas-related G-protein-coupled receptor subtype C (MrgC) Ubiquitination Calcium concentration 

Notes

Funding

This work was supported by National Natural Science Foundation of China (Nos. 81870871, 81400914) and Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health (QRX17138, ZKX18018).

Compliance with Ethical Standards

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical Approval

This experiment was approved by the Institution of Animal Care and Usage Committee at the Medical School of Nanjing University.

References

  1. 1.
    Mantyh P (2013) Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain 154:S54–S62.  https://doi.org/10.1016/j.pain.2013.07.044 Google Scholar
  2. 2.
    Oladosu FA, Maixner W, Nackley AG (2015) Alternative splicing of G protein-coupled receptors: relevance to pain management. Mayo Clin Proc 90(8):1135–1151.  https://doi.org/10.1016/j.mayocp.2015.06.010 Google Scholar
  3. 3.
    Geppetti P, Veldhuis NA, Lieu T, Bunnett NW (2015) G protein-coupled receptors: dynamic machines for signaling pain and itch. Neuron 88(4):635–649.  https://doi.org/10.1016/j.neuron.2015.11.001 Google Scholar
  4. 4.
    Wang D, Chen T, Zhou X, Couture R, Hong Y (2013) Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of mu-opioid receptor to Gi-protein in rat spinal dorsal horn. Neuroscience 253:455–464.  https://doi.org/10.1016/j.neuroscience.2013.08.069 Google Scholar
  5. 5.
    Zylka MJ, Dong X, Southwell AL, Anderson DJ (2003) Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc Natl Acad Sci USA 100(17):10043–10048.  https://doi.org/10.1073/pnas.1732949100 Google Scholar
  6. 6.
    Li Z, He SQ, Xu Q, Yang F, Tiwari V, Liu Q, Tang Z, Han L, Chu YX, Wang Y, Hin N, Tsukamoto T, Slusher B, Guan X, Wei F, Raja SN, Dong X, Guan Y (2014) Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in mice. Pain 155(8):1613–1621.  https://doi.org/10.1016/j.pain.2014.05.008 Google Scholar
  7. 7.
    Lembo PM, Grazzini E, Groblewski T, O’Donnell D, Roy MO, Zhang J, Hoffert C, Cao J, Schmidt R, Pelletier M, Labarre M, Gosselin M, Fortin Y, Banville D, Shen SH, Strom P, Payza K, Dray A, Walker P, Ahmad S (2002) Proenkephalin A gene products activate a new family of sensory neuron–specific GPCRs. Nat Neurosci 5(3):201–209.  https://doi.org/10.1038/nn815 Google Scholar
  8. 8.
    He SQ, Xu Q, Tiwari V, Yang F, Anderson M, Chen Z, Grenald SA, Raja SN, Dong X, Guan Y (2018) Oligomerization of MrgC11 and mu-opioid receptors in sensory neurons enhances morphine analgesia. Sci Signal 11(535):eaao3134.  https://doi.org/10.1126/scisignal.aao3134 Google Scholar
  9. 9.
    Tiwari V, Yang F, He SQ, Shechter R, Zhang C, Shu B, Zhang T, Tiwari V, Wang Y, Dong X, Guan Y, Raja SN (2016) Activation of peripheral mu-opioid receptors by dermorphin [D-Arg2, Lys4] (1-4) amide leads to modality-preferred inhibition of neuropathic pain. Anesthesiology 124(3):706–720.  https://doi.org/10.1097/ALN.0000000000000993 Google Scholar
  10. 10.
    Wang D, Wang P, Jiang J, Lv Q, Zeng X, Hong Y (2015) Activation of Mas oncogene-related G protein-coupled receptors inhibits neurochemical alterations in the spinal dorsal horn and dorsal root ganglia associated with inflammatory pain in rats. J Pharmacol Exp Ther 354(3):431–439.  https://doi.org/10.1124/jpet.115.225672 Google Scholar
  11. 11.
    He SQ, Han L, Li Z, Xu Q, Tiwari V, Yang F, Guan X, Wang Y, Raja SN, Dong X, Guan Y (2014) Temporal changes in MrgC expression after spinal nerve injury. Neuroscience 261:43–51.  https://doi.org/10.1016/j.neuroscience.2013.12.041 Google Scholar
  12. 12.
    He SQ, Li Z, Chu YX, Han L, Xu Q, Li M, Yang F, Liu Q, Tang Z, Wang Y, Hin N, Tsukamoto T, Slusher B, Tiwari V, Shechter R, Wei F, Raja SN, Dong X, Guan Y (2014) MrgC agonism at central terminals of primary sensory neurons inhibits neuropathic pain. Pain 155(3):534–544.  https://doi.org/10.1016/j.pain.2013.12.008 Google Scholar
  13. 13.
    Sun Y, Zhang J, Lei Y, Lu C, Hou B, Ma Z, Gu X (2016) Activation of spinal MrgC-Gi-NR2B-nNOS signaling pathway by Mas oncogene-related gene C receptor agonist bovine adrenal medulla 8–22 attenuates bone cancer pain in mice. Am J Transl Res 8(2):1144–1154Google Scholar
  14. 14.
    Sun YE, Lu CE, Lei Y, Liu Y, Ma Z, Gu X (2015) Mas-related G-protein-coupled receptor c agonist bovine adrenal medulla 8–22 attenuates bone cancer pain in mice. Int J Clin Exp Med 8(11):20178–20187Google Scholar
  15. 15.
    Li Z, He SQ, Tseng PY, Xu Q, Tiwari V, Yang F, Shu B, Zhang T, Tang Z, Raja SN, Wang Y, Dong X, Guan Y (2015) The inhibition of high-voltage-activated calcium current by activation of MrgC11 involves phospholipase C-dependent mechanisms. Neuroscience 300:393–403.  https://doi.org/10.1016/j.neuroscience.2015.05.043 Google Scholar
  16. 16.
    Kostenis E, Martini L, Ellis J, Waldhoer M, Heydorn A, Rosenkilde MM, Norregaard PK, Jorgensen R, Whistler JL, Milligan G (2005) A highly conserved glycine within linker I and the extreme C terminus of G protein alpha subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity. J Pharmacol Exp Ther 313(1):78–87.  https://doi.org/10.1124/jpet.104.080424 Google Scholar
  17. 17.
    Foot N, Henshall T, Kumar S (2017) Ubiquitination and the regulation of membrane proteins. Physiol Rev 97(1):253–281.  https://doi.org/10.1152/physrev.00012.2016 Google Scholar
  18. 18.
    Kalayil S, Bhogaraju S, Bonn F, Shin D, Liu Y, Gan N, Basquin J, Grumati P, Luo ZQ, Dikic I (2018) Insights into catalysis and function of phosphoribosyl-linked serine ubiquitination. Nature 557(7707):734–738.  https://doi.org/10.1038/s41586-018-0145-8 Google Scholar
  19. 19.
    Kong F, Liu Z, Jain VG, Shima K, Suzuki T, Muglia LJ, Starczynowski DT, Pasare C, Bhattacharyya S (2017) Inhibition of IRAK1 ubiquitination determines glucocorticoid sensitivity for TLR9-induced inflammation in macrophages. J Immunol 199(10):3654–3667.  https://doi.org/10.4049/jimmunol.1700443 Google Scholar
  20. 20.
    Popovic D, Vucic D, Dikic I (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20(11):1242–1253.  https://doi.org/10.1038/nm.3739 Google Scholar
  21. 21.
    Lai CY, Ho YC, Hsieh MC, Wang HH, Cheng JK, Chau YP, Peng HY (2016) Spinal Fbxo3-dependent Fbxl2 ubiquitination of active zone protein RIM1alpha mediates neuropathic allodynia through CaV2.2 activation. J Clin Neurosci NLM 36(37):9722–9738.  https://doi.org/10.1523/jneurosci.1732-16.2016 Google Scholar
  22. 22.
    Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16(2):109–110Google Scholar
  23. 23.
    Schwei Matthew J, Honore Prisca, Ramnaraine Margaret L, Rogers Scott D, Clohisy Denis R, Salak-Johnson Janeen L, Mantyh PW (1999) Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 19(24):10886–10897Google Scholar
  24. 24.
    Jiang J, Wang D, Zhou X, Huo Y, Chen T, Hu F, Quirion R, Hong Y (2013) Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms. Br J Pharmacol 170(5):1027–1040.  https://doi.org/10.1111/bph.12326 Google Scholar
  25. 25.
    Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative Assessment of Tactile Allodynia in the Rat Paw. J Neurosci Meth 53(1):55–63.  https://doi.org/10.1016/0165-0270(94)90144-9 Google Scholar
  26. 26.
    Glare PA, Davies PS, Finlay E, Gulati A, Lemanne D, Moryl N, Oeffinger KC, Paice JA, Stubblefield MD, Syrjala KL (2014) Pain in cancer survivors. J Clin Oncol 32(16):1739–1747.  https://doi.org/10.1200/JCO.2013.52.4629 Google Scholar
  27. 27.
    Gu X, Zhang J, Ma Z, Wang J, Zhou X, Jin Y, Xia X, Gao Q, Mei F (2010) The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain. Eur J Pain 14(5):496–502.  https://doi.org/10.1016/j.ejpain.2009.09.001 Google Scholar
  28. 28.
    Ren BX, Gu XP, Zheng YG, Liu CL, Wang D, Sun YE, Ma ZL (2012) Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model. Anesthesiology 116(1):122–132.  https://doi.org/10.1097/ALN.0b013e31823de68d Google Scholar
  29. 29.
    Raehal KM, Schmid CL, Groer CE, Bohn LM (2011) Functional selectivity at the mu-opioid receptor: implications for understanding opioid analgesia and tolerance. Pharmacol Rev 63(4):1001–1019.  https://doi.org/10.1124/pr.111.004598 Google Scholar
  30. 30.
    Liao Y, Xu M (2017) Efficacy and mechanism of action of etanercept in bone cancer pain. Pharmazie 72(4):219–222.  https://doi.org/10.1691/ph.2017.6901 Google Scholar
  31. 31.
    Lee JA, Xing Y, Nguyen D, Xie J, Lee CJ, Black DL (2007) Depolarization and CaM kinase IV modulate NMDA receptor splicing through two essential RNA elements. PLoS Biol 5(2):e40.  https://doi.org/10.1371/journal.pbio.0050040 Google Scholar
  32. 32.
    O’Leary H, Liu WH, Rorabaugh JM, Coultrap SJ, Bayer KU (2011) Nucleotides and phosphorylation bi-directionally modulate Ca2 +/calmodulin-dependent protein kinase II (CaMKII) binding to the N-methyl-D-aspartate (NMDA) receptor subunit GluN2B. J Biol Chem 286(36):31272–31281.  https://doi.org/10.1074/jbc.M111.233668 Google Scholar
  33. 33.
    Wild AR, Jones S, Gibb AJ (2014) Activity-dependent regulation of NMDA receptors in substantia nigra dopaminergic neurones. J Physiol 592(4):653–668.  https://doi.org/10.1113/jphysiol.2013.267310 Google Scholar
  34. 34.
    Liu Y, Cui X, Sun YE, Yang X, Ni K, Zhou Y, Ma Z, Gu X (2014) Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice. Anesth Analg 118(6):1345–1354.  https://doi.org/10.1213/ANE.0000000000000202 Google Scholar
  35. 35.
    Pickart CM, Eddins MJ (2004) Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 1695(1–3):55–72.  https://doi.org/10.1016/j.bbamcr.2004.09.019 Google Scholar
  36. 36.
    Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82(2):373–428.  https://doi.org/10.1152/physrev.00027.2001 Google Scholar
  37. 37.
    Kenakin T (2009) Biased agonism. F1000 Biol Rep 1:87.  https://doi.org/10.3410/b1-87 Google Scholar
  38. 38.
    Critchley WR, Pellet-Many C, Ringham-Terry B, Harrison MA, Zachary IC, Ponnambalam S (2018) Receptor tyrosine kinase ubiquitination and de-ubiquitination in signal transduction and receptor trafficking. Cells 7(3):22.  https://doi.org/10.3390/cells7030022 Google Scholar
  39. 39.
    Hsieh MC, Ho YC, Lai CY, Chou D, Chen GD, Lin TB, Peng HY (2018) Spinal TNF-alpha impedes Fbxo45-dependent Munc13-1 ubiquitination to mediate neuropathic allodynia in rats. Cell Death Dis 9(8):811.  https://doi.org/10.1038/s41419-018-0859-4 Google Scholar
  40. 40.
    Cachemaille M, Laedermann CJ, Pertin M, Abriel H, Gosselin RD, Decosterd I (2012) Neuronal expression of the ubiquitin ligase Nedd4-2 in rat dorsal root ganglia: modulation in the spared nerve injury model of neuropathic pain. Neuroscience 227:370–380.  https://doi.org/10.1016/j.neuroscience.2012.09.044 Google Scholar
  41. 41.
    Cheng W, Chen YL, Wu L, Miao B, Yin Q, Wang JF, Fu ZJ (2016) Inhibition of spinal UCHL1 attenuates pain facilitation in a cancer-induced bone pain model by inhibiting ubiquitin and glial activation. Am J Transl Res 8(7):3041–3048Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Anesthesiology, Affiliated Drum Tower HospitalNanjing University Medical CollegeNanjingPeople’s Republic of China

Personalised recommendations